BRAINSTORM CELL THERAPEUTICS INC. Warrants and Rights Outstanding
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) had Warrants and Rights Outstanding of $0 as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:WarrantsAndRightsOutstanding · last filed 2026-03-31
- 2025-12-31: Warrants and Rights Outstanding $0.00.
- 2024-12-31: Warrants and Rights Outstanding $447.00K.
- 2015-12-31: Warrants and Rights Outstanding $0.00.
- 2015-09-30: Warrants and Rights Outstanding $0.00.
| Period end | Warrants and Rights Outstanding |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-31 |
| 2024-12-31 | $447.00K 10-K · filed 2026-03-31 |
| 2015-12-31 | $0.00 10-K · filed 2016-03-09 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-16 |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-13 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-14 |
| 2014-12-31 | $123.00K 10-K · filed 2016-03-09 |
| 2014-09-30 | $104.00K 10-Q · filed 2014-11-13 |
| 2014-06-30 | $142.00K 10-Q · filed 2014-08-12 |
| 2014-03-31 | $1.73M 10-Q · filed 2014-05-13 |
| 2013-12-31 | $655.00K 10-K · filed 2015-03-26 |
| 2012-12-31 | $0.00 10-K · filed 2014-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |